Literature DB >> 19197451

Risk of late-onset hypogonadism (andropause) in Brazilian men over 50 years of age with osteoporosis: usefulness of screening questionnaires.

Ruth Clapauch1, Daniel Jorge de Castro Braga, Lizanka Paola Marinheiro, Salo Buksman, Yolanda Schrank.   

Abstract

OBJECTIVE: To analyze the relative risk of late-onset hypogonadism in men with osteoporosis and the usefulness of screening questionnaires.
METHODS: We correlated the Aging Male's Symptoms (AMS), Androgen Deficiency in Aging Male (ADAM) and International Index of Erectile Function (IIEF-5) questionnaires and the laboratory diagnosis of hypogonadism in 216 men aged 50-84 years (110 with osteoporosis and 106 with normal bone density, paired by age and ethnicity).
RESULTS: Hypogonadism presented in 25% of the osteoporotic and in 12.2 % of normal bone density men (OR 2.08; IC95%: 1.14-3.79) and was associated with ADAM first question (low libido, p=0.013). Levels of TT below 400 ng/dl correlated with an AMS score above 26 (p=0.0278). IIEF-5 showed no correlation with testosterone levels.
CONCLUSION: Hypogonadism was 2.08 times more prevalent in osteoporotic men. The symptom that best correlated with late-onset hypogonadism was low libido (ADAM 1 positive).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19197451     DOI: 10.1590/s0004-27302008000900006

Source DB:  PubMed          Journal:  Arq Bras Endocrinol Metabol        ISSN: 0004-2730


  2 in total

Review 1.  Predicting low testosterone in aging men: a systematic review.

Authors:  Adam C Millar; Adrian N C Lau; George Tomlinson; Alan Kraguljac; David L Simel; Allan S Detsky; Lorraine L Lipscombe
Journal:  CMAJ       Date:  2016-06-20       Impact factor: 8.262

2.  The role of clomiphene citrate in late onset male hypogonadism.

Authors:  Carlos Teodósio Da Ros; Lucas Uglione Da Ros; João Pedro Uglione Da Ros
Journal:  Int Braz J Urol       Date:  2022 Sep-Oct       Impact factor: 3.050

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.